on 26 Mar 2019
Last Applicant/ Owned by
EmpowerPharm Inc.
5575 North Service Road, Suite 603, Burlington, Ontario
, , L7L 6M1
Serial Number
UK00003386878 filed on 26th Mar 2019
Registration Number
UK00003386878 registered on
14th Jun 2019
Correspondent Information
J A Kemp LLP
80 Turnmill Street
London,
EC1M 5QU
Natural health products, namely, glucosamine, turmeric supplements, digestive health supplements, melatonin, sleep support supplements, fish oils, probiotics in tablet, capsule, gummy vitamin and liquid form; vitamin supplements; mineral supplements; vitamin and mineral food supplements; vitamin and mineral dietary supplements; vitamin preparations; mineral preparations; multivitamins; prenatal vitamins; calcium; magnesium in tablets, capsules, gummies and liquids; dietary supplements for promoting weight loss; over the counter medications for treating aches, pains, headaches, arthritis pain, sprains, and other minor joint and muscle problems, nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, naproxen sodium, acetaminophen, cold, sore throat and cough medications, guaifenesin, liquid cough medicines with dextromethorphan, decongestant nasal sprays, pseudoephedrine, phenylephrine, allergy medications, antihistamine pills and liquids, diphenhydramine, chlorpheniramine, brompheniramine, loratadine, fexofenadine, cetirizine, stomach upset medications, antidiarrhea medicines, loperamide, bismuth, nausea and vomiting, motion sickness, dimenhydrinate; cannabidiol (CBD); cannabidiol (CBD) suppositories, sublingual doses, creams, ointments, mucous membrane doses; tablets, capsules, gummies suppositories, skin patches, sublingual doses, extended release tablets and liquids for therapeutic purposes containing cannabidiol (CBD); herbal supplements containing cannabidiol (CBD); Liquid nutritional supplements containing cannabidiol (CBD) for treating, reducing or improving symptoms of various conditions, namely, pain, anxiety, depression, cancer, acne, skin conditions, neuroprotection, cardiovascular health, arthritis, inflammation, autoimmune conditions, epileptic seizures, nausea, appetite, inflammatory bowel disease, and insomnia; tetrahydrocannabinol (THC) products in sublingual doses and mucous membrane doses; tablets, capsules, gummies, suppositories, skin patches, sublingual doses, extended release tablets and liquid for therapeutic purposes containing THC and containing a combination of THC together with CBD.
UK00003386878
Figurative
Individual